324 related articles for article (PubMed ID: 24124874)
1. Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer.
Berzofsky JA; Wood LV; Terabe M
Expert Rev Vaccines; 2013 Oct; 12(10):1115-8. PubMed ID: 24124874
[No Abstract] [Full Text] [Related]
2. Cancer vaccines in the new era of cancer immunotherapy.
Knutson KL; Mittendorf EA
Vaccine; 2015 Dec; 33(51):7376. PubMed ID: 26432907
[No Abstract] [Full Text] [Related]
3. New developments in cancer vaccines.
Buonaguro L; Aurisicchio L; Buonaguro FM; Ciliberto G
Expert Rev Vaccines; 2013 Oct; 12(10):1109-10. PubMed ID: 24124872
[No Abstract] [Full Text] [Related]
4. Therapeutic cancer vaccines: a long and winding road to success.
Baxevanis CN; Papamichail M; Perez SA
Expert Rev Vaccines; 2014 Jan; 13(1):131-44. PubMed ID: 24224539
[TBL] [Abstract][Full Text] [Related]
5. Increasing immunogenicity of cancer vaccines to improve their clinical outcome.
Parmiani G; Cimminiello C; Maccalli C
Expert Rev Vaccines; 2013 Oct; 12(10):1111-3. PubMed ID: 24124873
[No Abstract] [Full Text] [Related]
6. Overview of the cancer vaccine field: are we moving forward?
Kudrin A; Hanna MG
Hum Vaccin Immunother; 2012 Aug; 8(8):1135-40. PubMed ID: 22854670
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the development of an autologous heat shock protein based anti-tumor vaccine.
Reitsma DJ; Combest AJ
Hum Vaccin Immunother; 2012 Aug; 8(8):1152-5. PubMed ID: 22854658
[No Abstract] [Full Text] [Related]
8. Cancer vaccines: are we there yet?
Hanna MG
Hum Vaccin Immunother; 2012 Aug; 8(8):1161-5. PubMed ID: 22854657
[TBL] [Abstract][Full Text] [Related]
9. Cancer vaccines and immunotherapy.
Tang H
Hum Vaccin; 2009 Oct; 5(10):666. PubMed ID: 19855174
[No Abstract] [Full Text] [Related]
10. Cancer vaccine development represents a particularly interesting and active field.
Ellis R; Riedmann EM
Hum Vaccin Immunother; 2012 Aug; 8(8):1013. PubMed ID: 22914448
[No Abstract] [Full Text] [Related]
11. Adventures of a vaccinologist entrepreneur.
Sardesai NY
Hum Vaccin Immunother; 2014; 10(6):1431-5. PubMed ID: 25264689
[No Abstract] [Full Text] [Related]
12. Letter from the Editor.
Ellis R
Hum Vaccin Immunother; 2015; 11(10):2333. PubMed ID: 26376012
[No Abstract] [Full Text] [Related]
13. Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations.
Gatti-Mays ME; Redman JM; Collins JM; Bilusic M
Hum Vaccin Immunother; 2017 Nov; 13(11):2561-2574. PubMed ID: 28857666
[TBL] [Abstract][Full Text] [Related]
14. Personalized cancer neoantigen vaccines come of age.
Chu Y; Liu Q; Wei J; Liu B
Theranostics; 2018; 8(15):4238-4246. PubMed ID: 30128050
[TBL] [Abstract][Full Text] [Related]
15. Cancer vaccines: looking to the future. Interview by Jenaid Rees.
Apostolopoulos V
Expert Rev Vaccines; 2013 Oct; 12(10):1125-6. PubMed ID: 24093953
[TBL] [Abstract][Full Text] [Related]
16. Nobel goes to immune checkpoint-Innovative cancer treatment by immunotherapy.
Li J; Dong C
Sci China Life Sci; 2018 Nov; 61(11):1445-1450. PubMed ID: 30377902
[No Abstract] [Full Text] [Related]
17. Various ways to improve whole cancer cell vaccines.
Cicchelero L; de Rooster H; Sanders NN
Expert Rev Vaccines; 2014 Jun; 13(6):721-35. PubMed ID: 24758597
[TBL] [Abstract][Full Text] [Related]
18. [New directions in immunotherapy for malignant solid tumors].
Okuno K; Sugiura F; Sukegawa Y; Inoue K
Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for cancer: focusing on developing treatments rather than drugs.
Sznol M
Curr Opin Investig Drugs; 2001 Jul; 2(7):957-8. PubMed ID: 11757798
[No Abstract] [Full Text] [Related]
20. Autologous heat-shock protein vaccines.
Colaco C
Hum Vaccin Immunother; 2013 Feb; 9(2):275-6. PubMed ID: 23291947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
